Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Ortho Regenerative Technologies Inc C.ORTH

Alternate Symbol(s):  ORTIF

Ortho Regenerative Technologies Inc is an orthopedic biotechnology company. It is engaged in a research and development biotechnology company specializing in regenerative medical products that repair and regenerate damaged joints thereby helping to prevent or delay the onset of Osteoarthritis. The products are based on a proprietary platform consisting of the biopolymer chitosan.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:ORTH)

Fundamentals Snapshot (CSE:ORTH)

Opinion & Analysis (CSE:ORTH)

No current opinion is available.

Bullboard Posts (CSE:ORTH)

Q1 Results.. some nice progress happening now IMO

Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023...
RockLobster1 - June 24, 2022

INITIATES PATIENTS RECRUITMENT

ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL ...
RockLobster1 - June 13, 2022

RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT CSE: ORTH

New patent issued by U.S. Patent and Trademark Office to protect core IP until 2035   Positions Company as leading player...
Betteryear2 - May 4, 2022

RE:MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL

finally some real progress.... should be finally some results to show coming.
RockLobster1 - February 7, 2022

MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL

MONTREAL, Feb. 7, 2022 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho" or the "Company...
RockLobster1 - February 7, 2022

U.S. IND CLINICAL HOLD LIFTED BY THE FDA

MONTREAL, Dec. 13, 2021 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("...
Betteryear2 - December 13, 2021